Literature DB >> 11981564

U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells.

Makoto Miyagishi1, Kazunari Taira.   

Abstract

The first evidence for gene disruption by double-stranded RNA (dsRNA) came from careful analysis in Caenorhabditis elegans. This phenomenon, called RNA interference (RNAi), was observed subsequently in various organisms, including plants, nematodes, Drosophila, and protozoans. Very recently, it has been reported that in mammalian cells, 21- or 22-nucleotide (nt) RNAs with 2-nt 3' overhangs (small inhibitory RNAs, siRNAs) exhibit an RNAi effect. This is because siRNAs are not recognized by the well-characterized host defense system against viral infections, involving dsRNA-dependent inhibition of protein synthesis. However, the current method for introducing synthetic siRNA into cells by lipofection restricts the range of applications of RNAi as a result of the low transfection efficiencies in some cell types and/or short-term persistence of silencing effects. Here, we report a vector-based siRNA expression system that can induce RNAi in mammalian cells. This technical advance for silencing gene expression not only facilitates a wide range of functional analysis of mammalian genes but might also allow therapeutic applications by means of vector-mediated RNAi.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11981564     DOI: 10.1038/nbt0502-497

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  172 in total

1.  Independent combinatorial effect of antisense oligonucleotides and RNAi-mediated specific inhibition of the recombinant rat P2X3 receptor.

Authors:  Maja Hemmings-Mieszczak; Gabriele Dorn; François J Natt; Jonathan Hall; William L Wishart
Journal:  Nucleic Acids Res       Date:  2003-04-15       Impact factor: 16.971

2.  Functional siRNA expression from transfected PCR products.

Authors:  Daniela Castanotto; Haitang Li; John J Rossi
Journal:  RNA       Date:  2002-11       Impact factor: 4.942

3.  Retroviral delivery of small interfering RNA into primary cells.

Authors:  Gregory M Barton; Ruslan Medzhitov
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

4.  Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA.

Authors:  Oliver Pusch; Daniel Boden; Rebecca Silbermann; Fred Lee; Lynne Tucker; Bharat Ramratnam
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

5.  Inducible shRNA expression for application in a prostate cancer mouse model.

Authors:  Frank Czauderna; Ansgar Santel; Michael Hinz; Melanie Fechtner; Birgit Durieux; Gerald Fisch; Frauke Leenders; Wolfgang Arnold; Klaus Giese; Anke Klippel; Jörg Kaufmann
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

6.  RNAi functions in cultured mammalian neurons.

Authors:  Anna M Krichevsky; Kenneth S Kosik
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

7.  A simple and cost-effective method for producing small interfering RNAs with high efficacy.

Authors:  Muhammad Sohail; Graeme Doran; Johann Riedemann; Val Macaulay; Edwin M Southern
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

8.  Effects on RNAi of the tight structure, sequence and position of the targeted region.

Authors:  Koichi Yoshinari; Makoto Miyagishi; Kazunari Taira
Journal:  Nucleic Acids Res       Date:  2004-02-03       Impact factor: 16.971

Review 9.  Applications of lentiviral vectors for shRNA delivery and transgenesis.

Authors:  Oded Singer; Inder M Verma
Journal:  Curr Gene Ther       Date:  2008-12       Impact factor: 4.391

10.  Adenoviral vectors expressing siRNAs for discovery and validation of gene function.

Authors:  Gert-Jan Arts; Ellen Langemeijer; Rudi Tissingh; Libin Ma; Heidi Pavliska; Kristina Dokic; Richele Dooijes; Emir Mesić; Remko Clasen; Frits Michiels; Jan van der Schueren; Mark Lambrecht; Sofie Herman; Reginald Brys; Kim Thys; Marcel Hoffmann; Peter Tomme; Helmuth van Es
Journal:  Genome Res       Date:  2003-09-15       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.